Halozyme Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $57k | 53k | 1.08 |
| 2025-03-31 | $21k | 20k | 1.05 |
| 2024-12-31 | $633k | 663k | 0.95 |
| 2024-09-30 | $1.1M | 1.1M | 1.00 |
| 2024-06-30 | $1.3M | 1.4M | 0.95 |
| 2024-03-31 | $1.0M | 1.2M | 0.88 |
| 2023-12-31 | $364k | 422k | 0.86 |
| 2023-09-30 | $1.1M | 1.3M | 0.85 |
| 2023-06-30 | $1.1M | 1.3M | 0.83 |
| 2022-12-31 | $12k | 12k | 1.00 |
| 2022-09-30 | $79k | 93k | 0.85 |
| 2022-03-31 | $4.0k | 5.0k | 0.80 |